NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance



    MILWAUKEE, Nov. 1 /CNW/ -- Merge Technologies Incorporated, d.b.a. Merge
Healthcare (Nasdaq:   MRGE; TSX: MRG), today announced that the Company received
a written notification from the NASDAQ Listing Qualifications Panel stating
that the panel determined to continue the listing of the Company's common
stock on The NASDAQ Stock Market subject to the Company's filing of its Form
10-Q for the quarter ended June 30, 2007 by no later than January 29, 2008. 
As indicated in the Company's news release dated October 29, 2007, the Company
currently expects to file, on or before December 31, 2007: (i) its restated
audited financial statements for the years ended December 31, 2004, 2005 and
2006, as well as other restated financial information previously included in
the Company's Annual Report on Form 10-K for the year ended December 31, 2006,
(ii) its restated unaudited financial statements included in its Quarterly
Report on Form 10-Q for the quarter ended March 31, 2007, and (iii) its
unaudited Quarterly Reports on Form 10-Q for the quarters ended June 30, 2007
and September 30, 2007.
    
    (Logo:  http://www.newscom.com/cgi-bin/prnh/20030430/MRGELOGO)
    
    Merge Healthcare is a market leader in the development and delivery of
medical imaging and information management software and services. Our
innovative software solutions use leading-edge imaging software technologies
that accelerate market delivery for our OEM customers, while our end-user
solutions improve our customers' productivity and enhance the quality of
patient care they provide. For additional information, visit our website at
http://www.mergehealthcare.com.
    All trademarks appearing in this release are the property of Cedara
Software Corp. and/or Merge Healthcare.
    
    Cautionary Notice Regarding Forward-Looking Statements
    
    This announcement may include forward-looking statements within the
meaning and subject to the protections of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934, as amended.  When
used in this announcement, the words "will," "believes," "intends,"
"anticipates," "expects" and similar expressions of the future are intended to
assist you in identifying such forward-looking statements.  Such
forward-looking statements include, among others, statements regarding the
timing of our completion of our restatements and filings of related SEC
reports.
    Any number of factors could cause the actual timing or results to differ
from the results contemplated by such forward-looking statements, including,
but not limited to:  the restatement may take longer to complete than
expected; the Company's inability to timely file reports with the Securities
and Exchange Commission; risks associated with the Company's inability to meet
the requirements of The NASDAQ Stock Market for continued listing, including
possible delisting; risks and effects of the past and current restatement of
financial statements of the Company and other actions that may be taken or
required as a result of such restatement; costs, risks and effects of legal
proceedings and investigations, including the formal investigation being
conducted by the Securities and Exchange Commission and class action,
derivative, and other lawsuits; the uncertainty created by and the adverse
impact on relationships with customers, potential customers, suppliers and
investors potentially resulting from, and other risks associated with, the
changes in the Company's senior management; and other risk factors detailed in
the Company's filings with the Securities and Exchange Commission.
    You should not place undue reliance on forward-looking statements, since
the statements speak only as of the date that they are made. We do not have,
or undertake any obligation to, publicly update, revise or correct any of the
forward-looking statements after the date of this announcement, or after the
respective dates on which such statements otherwise are made, whether as a
result of new information, future events or otherwise. This announcement
should be read in conjunction with the risk factors, financial information and
other information contained in the filings that the Company makes and
previously has made with the Securities and Exchange Commission.




For further information:

For further information: Melanie Gretzon, Director, Corporate Services
of  Merge Technologies Incorporated, +1-414-977-4000, ir@mergehealthcare.com
Web Site: http://www.merge-efilm.com

Organization Profile

MERGE TECHNOLOGIES INCORPORATED

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890